Concepedia

Acarbose attenuates the hypotensive response to sucrose and slows gastric emptying in the elderly

Diana Gentilcore, Belynda Bryant, Judith M. Wishart, Howard A. Morris, Michael Horowitz, Karen L. Jones

The American Journal of Medicine · 2005 · 84 citations · 42 references

DOI

Concepts

References

42

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

Jean‐Louis Chiasson, Robert G. Josse, Ramón Gomis et al. · The Lancet · 2002 · 2.5K citations

, , +14

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.

Michael A. Nauck, Markus M. Heimesaat, Jens J. Holst et al. · Journal of Clinical Investigation · 1993 · 1.6K citations · Full text

, , +15

Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose Tolerance

Jean‐Louis Chiasson, Robert G. Josse, Ramón Gomis et al. · JAMA · 2003 · 1.6K citations

, , +17

Reduced incretin effect in Type 2 (non-insulin-dependent) diabetes

Michael A. Nauck, F. Stöckmann, R. Ebert et al. · Diabetologia · 1986 · 1.3K citations · Full text

, , +13

Reduced Postprandial Concentrations of Intact Biologically Active Glucagon-Like Peptide 1 in Type 2 Diabetic Patients

Tina Vilsbøll, Thure Krarup, Carolyn F. Deacon et al. · Diabetes · 2001 · 884 citations · Full text

, , +16